Participate in Research

The CeDLara Study is for adults at least 18 years of age who have been diagnosed with celiac disease and are still experiencing symptoms, despite following a gluten-free diet.

The purpose of this study is to see if the study drug reduces symptoms of celiac disease when taken with a gluten-free diet.

You may qualify if you:

• Are 18 years of age or older
• Were diagnosed with celiac disease 6 or more months ago
• Are actively experiencing symptoms related to celiac disease
• Have been on a gluten-free diet for at least 6 months

Learn more at celiac-study.com/cdf.

The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015.

In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.

NO gluten challenge

Requirements:

• 18-70 years old
• Biopsy-confirmed celiac disease
• On a gluten-free diet for at least the last 12 months
• Still experiencing celiac disease symptoms

Learn more at proactiveceliac.com
Use referral code: REFCDF

Kanyos Bio is looking for volunteers with celiac disease to participate in the ACeD Study (Assessment of KAN-101 in Celiac Disease), a phase 1 clinical trial testing the investigational drug KAN-101.

KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens.

Requirements:

• 18-70 years old
• Biopsy-confirmed celiac disease
• On a gluten-free diet for at least the last 12 months

Learn more at Anokion.com/ACeD